Pathophysiological association of expression hormone of adipose tissue omentin-1 and the degree of vascular remodeling of brachyocephalic vessels in persons with obesity and disorders of carbohydrate metabolism
DOI:
https://doi.org/10.12775/JEHS.2020.10.10.012Keywords
omentin-1, obesity, type 2 diabetes mellitus, intima-media thickness, cardiovascular risk.Abstract
Introduction. The relationship of visceral obesity and excess body weight (EBW) with the development of cardiovascular diseases, type 2 diabetes mellitus (DM) and effect on quality and duration of life determine the relevance of studying this problem.
Objective: to assess omentin-1 metabolism and pathophysiological relationship between its level and the severity of lesions in the intima-media thickness (IMT) of the carotid arteries in type 2 DM in combination with EBW and obesity.
Material and research methods. We examined 98 people with DM, the first group consisted of 64 people with EBW and obesity, second group consisted of 34 people with normal body weight, control group – 28 healthy individuals.
Research results. Evaluation of the correlation matrix showed the presence of a positive rather strong negative connection between IMT, especially the right carotid artery and the level of omentin-1 in the blood (Rs = –0.55; p = 0.002). According to the results of the regression analysis and the study of the scatter diagram of the obtained data, the functional relationship between IMTright / IMTleft and the serum omentin-1 indicator was reliably approximated by a step-type model (polynomial curve, R = 0.49, R2 = 0.24, normalized R2 = 0.22 at F = 10.59, standard error 0.15, p <0.01)). The columnar bivariate 3D histogram clearly shows the physiological relationship between these indicators and indicates that the largest number of individuals with omentin-1 levels from 5-10 ng / ml had significant disorders of the vascular wall (IMT from 1.0 to 1.2 mm).
Conclusion. Obtained data indicate a statistically significant associative relationship between the dynamics of the predictor of cardiovascular risk – IMT with the degree of impaired expression of omentin-1.
References
Ohashi K, Shibata R, Murohara T, Ouchi N. Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab. 2014;25:348–355.
Ghoorah K, Campbell P, Kent A, Maznyczka A, Kunadian V. Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care. 2016;5(1):77–85.
Çimen AR, Cerit ET, Iyidir OT, Karakus R, Uyar BB, Toruner FB, Cakir N, Arslan M. Serum omentin-1 levels and endothelial dysfunction in obesity. Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):138-143. doi: 10.4183/aeb.2017.138. PMID: 31149164; PMCID: PMC6516446.
Pan X, Kaminga AC, Wen SW, Acheampong K, Liu A. Omentin-1 in diabetes mellitus: A systematic review and meta-analysis. PLoS One. 2019 Dec 10;14(12):e0226292. doi: 10.1371/journal.pone.0226292. PMID: 31821362; PMCID: PMC6903756.
Du Y, Ji Q, Cai L, Huang F, Lai Y, Liu Y, Yu J, Han B, Zhu E, Zhang J, Zhou Y, Wang Z, Zhao Y. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc Diabetol. 2016 Jun 28;15:90. doi: 10.1186/s12933-016-0406-5. PMID: 27352781; PMCID: PMC4924240.
Varona JF, Ortiz-Regalón R, Sánchez-Vera I, López-Melgar B, García-Durango C, Castellano Vázquez JM, Solís J, Fernández-Friera L, Vidal-Vanaclocha F. Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome. Arch Med Res. 2019 Feb;50(2):20-28. doi: 10.1016/j.arcmed.2019.05.003. Epub 2019 May 31. PMID: 31349950.
Sengul E, Duygulu G, Dindar S, Bunul F. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Ren Fail. 2013 Sep;35(8):1089-93. doi: 10.3109/0886022X.2013.817256. Epub 2013 Jul 25. PMID: 23883412.
Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011 Nov 22;10:103. doi: 10.1186/1475-2840-10-103. PMID: 22108456; PMCID: PMC3235986.
Cerit ET, Akturk M, Altinova AE, Tavil Y, Ozkan C, Yayla C, Altay M, Demirtas C, Cakir N. Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism. Endocrine. 2015 May;49(1):196-203. doi: 10.1007/s12020-014-0460-2. Epub 2014 Oct 25. PMID: 25344100.
Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract. 2011 Jul;93(1):21-5. doi: 10.1016/j.diabres.2011.03.001. Epub 2011 Apr 16. PMID: 21497934.
Varona JF, Ortiz-Regalón R, Sánchez-Vera I, López-Melgar B, García-Durango C, Castellano Vázquez JM, Solís J, Fernández-Friera L, Vidal-Vanaclocha F. Soluble ICAM 1 and VCAM 1 Blood Levels Alert on Subclinical Atherosclerosis in Non Smokers with Asymptomatic Metabolic Syndrome. Arch Med Res. 2019 Feb;50(2):20-28. doi: 10.1016/j.arcmed.2019.05.003. Epub 2019 May 31. PMID: 31349950.
Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, et al. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet (London, England). 2018;392(10161):2269–79. Epub 2018/10/09. 10.1016/s0140-6736(18)32328-6.
Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, et al. Adipokine levels are associated with insulin resistance in antipsychotics users independently of EBW. Psychoneuroendocrinology. 2019;103:87–95. Epub 2019/01/20. 10.1016/j.psyneuen.2019.01.001 .
Abdelraouf Korany M, Sonbol A, Mohamed Elgouhary S. Omentin-1 and diabetic retinopathy in type 2 diabetic patients. Alexandria Journal of Medicine. 2018;54(4):323–6. 10.1016/j.ajme.2018.04.003
Hayashi M, Morioka T, Hatamori M, Kakutani Y, Yamazaki Y, Kurajoh M, et al. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk. Diabetes Res Clin Pract. 2019;148:160–8. Epub 2019/01/15. 10.1016/j.diabres.2019.01.009.
Nezu T, Hosomi N, Aoki S, Matsumoto M. Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb. 2016;23(1):18-31. doi: 10.5551/jat.31989. Epub 2015 Oct 13. PMID: 26460381.
Bae JH, Kim WS, Lee MS, Kim KS, Park JB, Youn HJ, et al. The changes of individual carotid artery wall layer by aging and carotid intima-media thickness value for high risk. Cardiovasc Ther. 2016;34(6):397–403. doi: 10.1111/1755-5922.12209.
Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Sr., Gibbons R, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49–73.
Bots ML, Groenewegen KA, Anderson TJ, Britton AR, Dekker JM, Engstrom G, et al. Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration. Hypertension. 2014;63(6):1173–81. doi: 10.1161/HYPERTENSIONAHA.113.02683.
Jin Y, Kim D, Cho J, Lee I, Choi K, Kang H. Association between Obesity and Carotid Intima-Media Thickness in Korean Office Workers: The Mediating Effect of Physical Activity. Biomed Res Int. 2018 Aug 1;2018:4285038. doi: 10.1155/2018/4285038. PMID: 30155478; PMCID: PMC6093045.
Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011 Jul 21;365(3):213-21. doi: 10.1056/NEJMoa1012592. PMID: 21774709; PMCID: PMC3153949.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 501
Number of citations: 0